NCI-MATCH precision medicine trial makes major contributions to the use of tumor gene testing to select treatment for patients; new data has broad relevance in medicine and provides a roadmap for ...

The NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) cancer clinical trial is expanding with the opening of a new treatment arm. The addition, Arm Z1M, is a single-arm phase II study of a ...

Cancer therapies targeting specific genetic mutations may offer benefits to patients for whom other standard chemotherapy treatments have not effectively treated their tumor. However, genetic ...

Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials. Drew Huggins was running out of options. After his ...

Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study These survey results help identify barriers ...

The hunt for answers in the midst of this crisis continues. I am a journalist and most importantly a human being who is sorting out the fact that there is misinformation on the latest efforts to stay ...

Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy ...

Thousands of Fenerbahce fans shouted slogans outside a Turkish court house in support of the club's jailed president who went on trial on Tuesday, along with 92 other suspects, in a massive ...